CONTINUOUS AMBULATORY ELECTROCARDIOGRAPHIC MONITORING DURING 5-FLUOROURACIL THERAPY - A PROSPECTIVE-STUDY

被引:0
|
作者
REZKALLA, S
KLONER, RA
ALSARRAF, M
BHASIN, S
REVELS, S
ENSLEY, J
KERPELFRONIUS, S
OLIVENSTEIN, A
TURI, ZG
机构
[1] WAYNE STATE UNIV,DETROIT,MI 48202
[2] HARPER HOSP,DETROIT,MI 48201
来源
CLINICAL RESEARCH | 1988年 / 36卷 / 03期
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:A499 / A499
页数:1
相关论文
共 50 条
  • [31] LIFE THREATENING GASTROINTESTINAL TOXICITY DURING 5-FLUOROURACIL THERAPY
    BIRAN, S
    KRASNOKUKI, D
    BRUFMAN, C
    [J]. HAREFUAH, 1977, 93 (3-4) : 77 - 77
  • [32] Therapeutic monitoring of 120 hours continuous 5-fluorouracil associated with cisplatin.
    Coudert, B
    DeGislain, C
    Beltramo, JL
    Guigues, B
    Mayer, F
    Bruchon, Y
    Riedinger, JM
    Fargeot, P
    Dumas, M
    Guerrin, J
    [J]. BULLETIN DU CANCER, 1996, 83 (10) : 847 - 852
  • [33] Continuous Fetal Monitoring During Electroconvulsive Therapy: A Prospective Observation Study
    Rabie, Nader
    Shah, Ronak
    Ray-Griffith, Shona
    Coker, Jessica L.
    Magann, Everett F.
    Stowe, Zachary N.
    [J]. INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2021, 13 : 1 - 7
  • [34] THE ST SEGMENT DURING AMBULATORY ELECTROCARDIOGRAPHIC MONITORING
    ARMSTRONG, WF
    MORRIS, SN
    [J]. ANNALS OF INTERNAL MEDICINE, 1983, 98 (02) : 249 - 251
  • [35] Feasibility study of ambulatory continuous infusion of 5-fluorouracil followed by cisplatin through hepatic artery for metastatic colorectal cancer
    Baoli Qin
    Ken Kato
    Kenji Mitsugi
    Minoru Nakamura
    Risa Tanaka
    Eishi Baba
    Hiroshi Ariyama
    Toshiro Kuroiwa
    Mine Harada
    Shuji Nakano
    [J]. Cancer Chemotherapy and Pharmacology, 2006, 57 : 114 - 119
  • [36] Feasibility study of ambulatory continuous infusion of 5-fluorouracil followed by cisplatin through hepatic artery for metastatic colorectal cancer
    Qin, BL
    Kato, K
    Mitsugi, K
    Nakamura, M
    Tanaka, R
    Baba, E
    Ariyama, H
    Kuroiwa, T
    Harada, M
    Nakano, S
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (01) : 114 - 119
  • [37] 5-FLUOROURACIL (5-FU) IN PRIMARY TRABECULECTOMY - A PROSPECTIVE, RANDOMIZED STUDY
    GOLDENFELD, M
    WONG, P
    RUDERMAN, J
    ROSENBERG, L
    KRUPIN, T
    GEISER, D
    LIEBMANN, J
    RITCH, R
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1993, 34 (04) : 815 - 815
  • [38] PERITONEAL EOSINOPHILIA IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS - A PROSPECTIVE-STUDY
    CHAN, MK
    CHOW, L
    LAM, SS
    JONES, B
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1988, 11 (02) : 180 - 183
  • [39] Prospective randomized study of cyclophosphamide, epirubicin, and 5-fluorouracil versus cyclophosphamide, adriamycin, and 5-fluorouracil in advanced or recurrent breast cancer
    Kobayashi T.
    Koyama H.
    Oka T.
    Yasumura T.
    Kan N.
    Takatsuka Y.
    Noguchi M.
    Morimoto K.
    Suzuki T.
    Tobe T.
    Mori T.
    [J]. Breast Cancer, 1999, 6 (1) : 37 - 42
  • [40] 5-FLUOROURACIL AND ADRIAMYCIN THERAPY FOR HEPATOMA
    BAKER, LH
    VAITKEVICIUS, VK
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 215 - 215